Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M. G. Svaland"'
Publikováno v:
Neuroradiology. 38:537-541
Gadodiamide injection is a new nonionic paramagnetic, extracellular contrast medium. Its safety at a dose of 0.1 mmol/kg body weight was evaluated in a large European multicentre trial on adults referred for contrast-enhanced MRI of the central nervo
Publikováno v:
Acta Radiologica. 35:396-399
Gadodiamide injection was administered intravenously to 49 patients with known or suspected CNS lesions undergoing MR imaging. Two parallel groups were used to evaluate the efficacy and safety of single doses of 0.1 (25 patients) and 0.3 (24 patients
Publikováno v:
Journal of Magnetic Resonance Imaging. 4:419-423
This study compared the safety and tolerability of gadodiamide injection at the standard dose (0.1 mmol/kg) and at a higher dose (0.3 mmol/kg) in 289 patients participating in a parallel group multiple independent trial program. All patients had a kn
Publikováno v:
Acta Radiologica. 35:396-399
Gadodiamide injection was administered intravenously to 49 patients with known or suspected CNS lesions undergoing MR imaging. Two parallel groups were used to evaluate the efficacy and safety of single doses of 0.1 (25 patients) and 0.3 (24 patients
Publikováno v:
MAGMA Magnetic Resonance Materials in Physics, Biology, and Medicine. 1:169-175
Gadodiamide injection was administered intravenously to 48 patients with known or suspected central nervous system (CNS) lesions undergoing magnetic resonance imaging (MRI). Two parallel groups were examined to evaluate the efficacy and safety of sin
Publikováno v:
Investigative Radiology. 27:130-133
The pharmacokinetic properties of the x-ray contrast medium, iodixanol, a new nonionic dimer, were investigated in a phase I study including 40 healthy male volunteers. Iodixanol (300 mg I/mL) was administered intravenously (i.v.) at four dose levels
Autor:
K. J. Berg, P. E. Lillevold, L. Ressem, K. P. Nordal, F. Kolmannskog, K. Rootwelt, M. G. Svaland
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 52:27-33
Iopentol (mean dose 0.42 g I kg-1) was administered for abdominal aortography and pelvic angiography in 10 patients with advanced non-diabetic chronic renal failure (S-creatinine 672 +/- 259 mumol l-1, mean +/- SD). Renal glomerular function measured
Publikováno v:
Journal of Magnetic Resonance Imaging. 6:255-257
A meta-analyses was performed to evaluate the safety of gadodiamide injection (OM-NISCAN) for magnetic resonance imaging in two different age groups (65 years;or = 65 years). Data on vital signs, clinical laboratory parameters, and subjectively exper
Publikováno v:
Investigative Radiology. 29:S186-S188
Publikováno v:
Acta Radiologica. 33:482-484
Iopentol 350 mg I/ml was injected in doses of 265 to 533 mg I/kg b.w. (mean 417 mg I/kg b.w.) in 10 patients with advanced nondiabetic chronic renal failure (S-creatinine 672 ± 259 μmol/l (mean ± SD)). Urine (10 patients) and feces (7 patients) we